IRIS UniCatt

Bianchi, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.212
AS - Asia 4.712
EU - Europa 4.324
SA - Sud America 1.056
Continente sconosciuto - Info sul continente non disponibili 306
AF - Africa 128
OC - Oceania 11
AN - Antartide 1
Totale 17.750
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.970
SG - Singapore 2.078
DE - Germania 1.136
CN - Cina 1.002
IT - Italia 878
BR - Brasile 846
VN - Vietnam 611
SE - Svezia 521
FR - Francia 353
UA - Ucraina 252
PL - Polonia 248
GB - Regno Unito 199
BD - Bangladesh 174
IE - Irlanda 162
FI - Finlandia 158
IN - India 158
RU - Federazione Russa 137
JP - Giappone 136
ID - Indonesia 132
CA - Canada 121
HK - Hong Kong 100
AR - Argentina 82
MX - Messico 67
NL - Olanda 62
TR - Turchia 44
IQ - Iraq 43
AT - Austria 40
ES - Italia 37
ZA - Sudafrica 37
BE - Belgio 31
KR - Corea 27
VE - Venezuela 27
CO - Colombia 26
EC - Ecuador 26
PK - Pakistan 24
IR - Iran 21
AE - Emirati Arabi Uniti 19
EG - Egitto 18
UZ - Uzbekistan 18
MA - Marocco 16
SA - Arabia Saudita 15
CL - Cile 14
PE - Perù 13
PY - Paraguay 13
CH - Svizzera 12
CI - Costa d'Avorio 12
CZ - Repubblica Ceca 12
KE - Kenya 12
KZ - Kazakistan 12
AL - Albania 11
JM - Giamaica 11
PT - Portogallo 11
RO - Romania 11
CR - Costa Rica 10
MY - Malesia 10
AZ - Azerbaigian 9
JO - Giordania 9
LB - Libano 8
LT - Lituania 8
PH - Filippine 8
DO - Repubblica Dominicana 7
HU - Ungheria 7
IL - Israele 7
TN - Tunisia 7
GR - Grecia 6
LK - Sri Lanka 6
MD - Moldavia 6
UY - Uruguay 6
AU - Australia 5
BH - Bahrain 5
NP - Nepal 5
OM - Oman 5
SN - Senegal 5
BG - Bulgaria 4
ET - Etiopia 4
GE - Georgia 4
GT - Guatemala 4
HN - Honduras 4
QA - Qatar 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BB - Barbados 3
BO - Bolivia 3
BS - Bahamas 3
DZ - Algeria 3
EU - Europa 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
PA - Panama 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
DK - Danimarca 2
GA - Gabon 2
HR - Croazia 2
LV - Lettonia 2
NO - Norvegia 2
PS - Palestinian Territory 2
TH - Thailandia 2
VA - Santa Sede (Città del Vaticano) 2
Totale 17.415
Salva come PNG Salva come JPEG
Città #
Singapore 1.160
San Jose 731
Ashburn 692
Chandler 613
New York 262
Warsaw 222
Ho Chi Minh City 218
Beijing 203
Rome 201
Los Angeles 194
Dublin 150
Hanoi 140
San Mateo 128
Lauterbourg 121
Hefei 118
Ann Arbor 114
Tokyo 113
Milan 111
Jakarta 108
Dallas 101
Jacksonville 101
The Dalles 100
São Paulo 97
Wilmington 97
Fairfield 93
Hong Kong 88
Moscow 86
Munich 81
Frankfurt am Main 80
St Louis 79
Boston 76
Chicago 75
Nanjing 68
Tukwila 68
Helsinki 66
Houston 65
Seattle 65
Marseille 62
Santa Clara 62
Princeton 50
Woodbridge 50
Buffalo 49
Atlanta 48
Boardman 48
Bremen 48
Montreal 47
Kent 46
Nürnberg 46
Orem 46
Cattolica 41
Brooklyn 40
Turku 38
Da Nang 35
Dearborn 35
Denver 35
Nuremberg 33
London 32
Phoenix 32
Zhengzhou 32
Rio de Janeiro 31
Brussels 28
Cambridge 28
Council Bluffs 28
Lawrence 28
Redwood City 28
Hyderabad 26
Nanchang 25
North Bergen 24
Seoul 24
Mountain View 23
Paris 23
Stockholm 22
Amsterdam 21
Belo Horizonte 21
University Park 21
Bexley 20
Hangzhou 20
Mexico City 20
Shanghai 20
Haiphong 19
Johannesburg 19
Norwalk 19
Chennai 18
Toronto 18
San Francisco 17
Trieste 17
Vienna 17
Augusta 16
Baghdad 16
Düsseldorf 16
Shenyang 16
Tashkent 16
Lappeenranta 15
Las Vegas 15
Mumbai 15
Poplar 15
Guangzhou 14
Memphis 14
Tianjin 14
Hebei 13
Totale 8.860
Salva come PNG Salva come JPEG
Nome #
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 499
Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis. 415
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 364
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 360
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 345
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries 329
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 311
Increased estradiol levels in venous occlusive disorder: a possible functional mechanism of venous leakage. 283
Predictors of morbidity and mortality in acromegaly, an Italian survey. 263
Double pituitary adenomas 242
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 228
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 218
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 214
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 207
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 205
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 204
Assessment of neurological manifestations in hospitalized patients with COVID-19 203
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 176
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study 167
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 164
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 164
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 161
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 155
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 155
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 154
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 154
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 154
The Changing Clinical Spectrum of Hypophysitis 154
Pediatric craniopharyngiomas: magnetic resonance imaging assessment for hypothalamus-pituitary axis dysfunction and outcome prediction 152
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 150
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 150
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 148
Hypothalamitis: a diagnostic and therapeutic challenge 148
Hormonal and metabolic evaluation in Down's syndrome: preliminary evidence for TSH dysregulation in hyperthyrotropinemic patients 146
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 145
Spontaneous thyroid nodule hemorrhage in the emergency department 144
GH receptor isoforms and skeletal fragility in acromegaly 143
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 140
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 138
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 135
Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. 134
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 133
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas 133
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 131
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 130
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 130
Hypothalamitis and pituitary atrophy 130
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 130
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA 128
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 128
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 128
Genes of the “regulation of lymphocyte activation” pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors 127
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 124
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 123
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 122
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORS 122
Empty sella syndrome: Multiple endocrine disorders. 121
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy 120
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 120
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 119
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 117
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 117
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. 116
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency 116
Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors 115
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 115
Pregnancy in Autoimmune Hypophysitis: Management of a Rare Condition 115
LCM-RNAseq Highlights Intratumor Heterogeneity and a lncRNA Signature from Archival Tissues of GH-Secreting PitNETs 114
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 114
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 114
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 114
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 113
The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions 112
Understanding the effect of acromegaly on the human skeleton. 112
Acromegaly in the elderly patients 112
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 110
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 110
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 110
Vertebral fractures in patients with acromegaly: a 3-year prospective study 109
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 108
High prevalence of hyperplastic colonic polyps in acromegalic subjects 107
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 107
The Differential Diagnosis between Pseudo Cushing's Syndrome and True Cushing's Syndrome in a Septic Patient in the Pre-Agonal Phase: A Case Report 106
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 105
Neuropsychiatric symptoms, oral pigmentation and fever as revealing hints of autoimmune Addison’s disease 103
IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly 103
Diabetic neuropathy: a risk factor for severe COVID-19? 102
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 101
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 101
Empty sella syndrome: an update 100
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 99
Cytokines and chemokines modulate the growth of pituitary adenoma/neuroendocrine tumors: preliminary results of a monocenter prospective pilot study 99
Vertebral fractures in males with prolactinoma. 99
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 99
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 97
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 97
Clinical implications of the 2022 WHO classification on the multidisciplinary management of PitNETS patients 96
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU 93
Acromegaly can be cured by first-line pasireotide treatment? 93
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 93
Totale 15.183
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.028
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022701 0 0 10 73 87 34 21 130 26 49 110 161
2022/20231.720 193 228 140 272 101 236 98 142 182 24 65 39
2023/2024919 38 209 33 46 44 150 47 20 33 55 104 140
2024/20252.383 45 52 161 95 139 89 61 94 345 241 494 567
2025/20267.712 919 286 528 1.010 1.118 361 1.130 413 440 571 648 288
2026/20271.509 510 924 75 0 0 0 0 0 0 0 0 0
Totale 17.750